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Background: The technique of compartment-based radical hysterectomy was originally described by M Höckel as
total mesometrial resection (TMMR) for standard treatment of stage I and II cervical cancer. However, with regard to
the ontogenetically-defined compartments of tumor development (Müllerian) and lymph drainage (Müllerian and
mesonephric), compartments at risk may also be defined consistently in endometrial cancer. This is the first report
in the literature on the compartment-based surgical approach to endometrial cancer. Peritoneal mesometrial
resection (PMMR) with therapeutic lymphadenectomy (tLNE) as an ontogenetic, compartment-based oncologic
surgery could be beneficial for patients in terms of surgical radicalness as well as complication rates; it can be
standardized for compartment-confined tumors. Supported by M Höckel, PMMR was translated to robotic surgery
(rPMMR) and described step-by-step in comparison to robotic TMMR (rTMMR).
Methods: Patients (n = 42) were treated by rPMMR (n = 39) or extrafascial simple hysterectomy (n = 3) with/without
bilateral pelvic and/or periaortic robotic therapeutic lymphadenectomy (rtLNE) for stage I to III endometrial cancer,
according to International Federation of Gynecology and Obstetrics (FIGO) classification. Tumors were classified as
intermediate/high-risk in 22 out of 40 patients (55%) and low-risk in 18 out of 40 patients (45%), and two patients
showed other uterine malignancies. In 11 patients, no adjuvant external radiotherapy was performed, but
chemotherapy was applied.
Results: No transition to open surgery was necessary. There were no intraoperative complications. The
postoperative complication rate was 12% with venous thromboses, (n = 2), infected pelvic lymph cyst (n = 1),
transient aphasia (n = 1) and transient dysfunction of micturition (n = 1). The mean difference in perioperative
hemoglobin concentrations was 2.4 g/dL (± 1.2 g/dL) and one patient (2.4%) required transfusion. During follow-up
(median 17 months), one patient experienced distant recurrence and one patient distant/regional recurrence of
endometrial cancer (4.8%), but none developed isolated locoregional recurrence. There were two deaths from
endometrial cancer during the observation period (4.8%).
Conclusions: We conclude that rPMMR and rtLNE are feasible and safe with regard to perioperative morbidity,
thus, it seems promising for the treatment of intermediate/high-risk endometrial cancer in terms of surgical
radicalness and complication rates. This could be particularly beneficial for morbidly obese and seriously ill patients.* Correspondence: rainer.kimmig@uk-essen.de
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Figure 1 Right infundibulopelvic ligament. Arteria ovarica and
vena ovarica, the border to the right colon mesentery, and the
lymphatic anastomosis to the right inframesenteric periaortic lymph
nodes (arrows) are visible.
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Treatment of endometrial cancer is primarily surgical.
However, there is ongoing debate on the extent of surgi-
cal radicalness, predominantly with regard to lymphade-
nectomy (LNE). In addition, adjuvant radiotherapy has
been shown to improve local control but does not in-
crease survival probability. Indeed, adjuvant chemother-
apy seems to increase survival probability in patients
with high-risk endometrial cancer [1,2]. Surgical treat-
ment of endometrial cancer can be performed with
lower risk but apparently unaltered oncological effi-
ciency by minimally invasive surgery. This also holds
true for minimally invasive approaches and robotic sur-
gery [3-6].
Although there are many reports of the results of dif-
ferent surgical approaches, a standardization of surgical
treatment for intermediate/high-risk endometrial cancer
is missing. Standardization is crucial for the evaluation
of locoregional tumor control by surgery alone, as it has
been proposed for cervical cancer [7-9]. Applying the
findings of basic research on boundary formation and
maintenance in tissue development [10], as well as the
results of clinical research on ontogenetic compart-
ments of cancer spread in endometrial cancer [11], the
compartments of local and regional cancer spread can
be defined and surgical techniques adapted to remove
the compartments at risk entirely. In analogy to cer-
vical cancer, this may also impact upon locoregional
cancer recurrence in endometrial cancer without any
additional adjuvant radiotherapy. As proposed by M
Höckel, the technique of TMMR can be modified and
adapted to localization and lymph drainage of endo-
metrial cancer, with regard to the paramesonephric-
mesonephric-Müllerian tubercle complex-derived tissue
compartments (personal communication).
In this paper, we describe the resulting technique of
peritoneal mesometrial resection (PMMR), which has
been translated from open to robotic surgery (rPMMR).
Clinical outcome data are reported first.
Methods
Surgical technique
The training of the first author, the development and de-
scription of the surgical technique of robotic total
mesometrial resection (rTMMR) and periaortic robotic
therapeutic lymphadenectomy (rtLNE) have recently
been described [12,13]. In close cooperation with M
Höckel, the method of rPMMR has been developed and
surgical steps to remove ontogenetically-derived com-
partments of permissive tumor progression have been
defined. Although endometrial cancer also arises within
the Müllerian compartment, there are two important
differences to cervical cancer with regard to tumor
site and compartment-related tumor progression. Itis important to note that the technique of PMMR
and therapeutic lymphadenectomy (note: “therapeutic”
means “therapeutically intended”) (tLNE) is deduced
from the research on embryonic development of organ
compartments and stringent control of compartment
borders; however, it has not yet been proven by clin-
ical studies.
The first difference is that there is an additional down-
stream lymphatic drainage along the mesonephric-derived
ovarian vessel system into the periaortic nodes (Figure 1).
The second difference is that there is no drainage into
the deep preischiadic nodes via the ligamentous
(fibrofatty) mesometria, as long as there is no distal cer-
vical stromal infiltration.
On the other hand, the drainage along the vascular
mesometrium is almost identical to cervical cancer,
using the same lymph channels along the uterine vessels
into the external, internal and common iliac nodes.
Thus, with regard to the technique of radical hysterec-
tomy, the vascular mesometrium should be resected
in endometrial cancer almost identically to cervical can-
cer. However, the ligamentous mesometrium, that is
sacrouterine and rectovaginal ligaments, may be left in
situ if there is no cervical involvement. Furthermore, it
is important to remove the vascular anastomoses be-
tween the uterine and ovarian vessel system, to guaran-
tee clearance of the whole Müllerian and mesonephric
compartment at risk. This can be achieved by en bloc re-
section of the entire broad ligament together with the
peritoneum covering this tissue region. With regard to
locoregional spread, complete bilateral resection of ad-
nexa and infundibulopelvic ligaments including interca-
lated lymph nodes is mandatory. With regard to parietal
LNE, pelvic and periaortic nodes represent primary ba-
sins, thus implying a complete bilateral pelvic and
periaortic LNE in case of therapeutic intent as previously
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drainage via the ligamentous mesometria in endometrial
cancer, the deep preischiadic nodes may be left in situ.
The resulting technique of rPMMR will be described
in detail, step-by-step. Particular steps are identical to
rTMMR and the accordant technique has been previ-
ously described [13].
Patients
As a first proof of feasibility, 39 out of 42 patients with
stage I to III endometrial cancer, according to Inter-
national Federation of Gynecology and Obstetrics
(FIGO) classification, were treated by rPMMR with or
without rtLNE; 3 out of 42 patients with low-risk endo-
metrial cancer underwent robotically-assisted, non-
modified total laparoscopic hysterectomy (TLH). The
median age of patients was 59 years (range 26 to
81 years) and the mean body mass index (BMI) was
31 kg/m2 (range 18 to 57 kg/m2). There were 40 pa-
tients with endometrial carcinoma (endometroid, 34
patients; serous, three patients; clear cell, one patient;
adenosquamous, one patient; and squamous, one pa-
tient), one patient with a mixed Müllerian tumor and
one patient with a rhabdomyosarcoma. FIGO stages of
endometrial carcinomas were distributed: stage IA, 21
patients; stage IB, ten patients; stage II, three patients;
stage IIIA, one patient; and stage IIIC, five patients.
There were five patients with grade I, 25 patients with
grade II and ten patients with grade III tumors. Four
tumors showed lymphangiosis.
tLNE was performed by robotic surgery in analogy to
the procedure described by Höckel [9,11] and Kimmig
et al. [12]. None of the patients with grade I tumors
underwent LNE. Six patients presented with nodal me-
tastasis, and the number of positive nodes was 1, 1, 2, 3,
5 and 24, respectively. The total number of nodes re-
moved is shown in Results. However, with regard to
compartmental-defined radical surgery, complete clear-
ance of lymph basins and connecting intercalated nodes
downstream to the tumor was defined as a superior
quality parameter to the number of nodes. Intercalated
nodes are embryonically ‘immigrated’ nodes connecting
the lymph system of the organ compartment to the
lymph basins. For endometrial cancer (uterine pathway),
these include: intercalated mesometrial nodes (mm),
paravisceral nodes (internal iliac nodes excluding gluteal
and rectal nodes) (pv), external iliac nodes (ei), common
iliac nodes (ci) and presacral/subaortic nodes (ps) on
both sides. Additionally, surgery was extended follow-
ing the lymphatic ovarian drainage including the
ovarian pathway and intercalated infundibulopelvic
nodes (ifp), and periaortic nodes including inframesenteric
nodes (im) and supramesenteric/infrarenal nodes (sm/ir).
Perioperative morbidity and early postoperative morbiditywere analyzed. In addition, frequency of perioperative
blood transfusions and differences in perioperative
hemoglobin concentrations were noted. The tumor-
related outcome was recorded.
Statistical analysis
Analysis of clinical and histopathological data was
performed using SPSS (Chicago, IL, USA) version 17.0
for Macintosh. Considering the limited number of pa-
tients and the explorative character of this study, we
conducted a descriptive analysis only.
Technique and results
Preparation of robotically-assisted laparoscopy and trocar
positioning
Patients were placed in the Trendelenburg position with
at least 25 to 30 degrees, and with side-docking of the
patient cart. The trocars were positioned with the cam-
era trocar approximately 5 to 10 cm supra-umbilically
and two lateral robotic trocars approximately 5 to 10 cm
above the upper anterior iliac spine on both sides, that
is, one additional robotic trocar on the left between the
camera trocar and the left lateral trocar, and one assist-
ant trocar of 10 mm diameter on the right side between
camera trocar and right lateral trocar. At least 10 cm be-
tween the trocar incisions assured free and adequate
mobility. Before rPMMR, bilateral pelvic and periaortic
rtLNE were performed as outlined in Kimmig et al. [12].
Concomitantly to the removal of lymph nodes, the
infundibulopelvic ligaments containing lymph vessels
and intercalated nodes were completely exposed and to-
tally resected. The anastomoses to the periaortic lymph-
atic system, at the level of the aorta, caval vein and renal
veins, were kept intact and mobilized without separ-
ation. All regional nodes were then removed, except for
the intercalated mesometrial nodes located predomin-
antly in the vascular mesometrium.
Prior to the standardized description of rPMMR, the
principles and nomenclature of the technique by M
Höckel should be kept in mind. As shown in Figure 2a,
the Müllerian compartment consists of the uterus,
fallopian tubes and vascular mesometria/mesocolpia;
corresponding to the tissue surrounding and accom-
panying the uterine vessels to the iliac vessels, and the
vesicouterine ligaments anteriorly and ligamentous
mesometria dorsally; corresponding to the fibrofatty
sacrouterine and rectouterine/vaginal ligaments, and
the proximal vagina. According to the technique, all of
these structures should be completely removed, except
for the ligamentous mesometria and the vagina with
wide tumor-free margins. Nevertheless, the inferior
hypogastric plexus should be identified in order to safely
separate it from the vascular mesometrium. Additionally,
the intercalated tissue between the Müllerian-derived
Figure 2 The structures of the female genital tract with reference to the embryologic Müllerian and mesonephric compartment. The
accordant structures resected in endometrial cancer are colored dark green for the Müllerian Compartment (a) and blue for the mesonephric
lymphatic drainage (b), ovarian and infundibulopelvic system). The parts of the Müllerian compartment that are only resected in stage II or III
disease are colored light green. Modified from Höckel [14] and Hepp et al. [15], with permission of Elsevier and Urban &
Schwarzenberg, respectively.
Figure 3 Separation of the right infundibulopelvic ligament
from the right mesocolon and dissection of connecting vessels.
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sonephric origin should be removed entirely, together with
the ovary and the ovarian vessel system due to the lymph-
atic drainage of the uterine corpus (Figure 2b).
The procedure of rPMMR and rtLNE starts by opening
the peritoneum laterally to the right infundibulopelvic
ligament at the level of the right common iliac artery.
Step 1
First, the peritoneum is incised laterally to the right iliac
common artery and the right infundibulopelvic ligament,
and divided cranially to expose the anterior aspect of the
vena cava, the right ureter, the right infundibulopelvic
ligament and the right colon mesentery. Usually, lymph-
atic anastomoses between the infundibulopelvic ligament
and the low right periaortic nodes can be identified
(Figure 1).
Step 2
The border between the mesonephric compartment of
the infundibulopelvic ligament and the right colon
mesentery is identified, and the structures are sepa-
rated. Anastomosing vessels are identified and sealed
(Figure 3).
Step 3
The infundibulopelvic ligament is elevated and dissected
from laterally to medially, keeping the connections tothe periaortic lymphatic system intact, and separating it
from the right ureter and mesureter dorsally (Figure 4).Step 4
Resection of the right infundibulopelvic ligament,
following the dissection of ovarian vessels at their origin
together with periaortic LNE, is performed completely
up to the renal vessels, including the nodes located
between and dorsally of the vena cava and aorta as pre-
viously described [12]. The right infundibulopelvic
Figure 4 Mobilization of the right infundibulopelvic ligament
from laterally to medially and resection together with adherent
periaortic nodes ventrally of the vena cava. The ureter and the
vessels supplying the mesureter are preserved and mobilized.
Figure 6 Same preparation of the left side. Following dissection
of the ovarian vessels at their aortic and renal origin on the left, the
infundibulopelvic ligament is dissected from the left mesocolon and
followed through a prepared channel dorsally to the mesosigmoid.
The left infrarenal periaortic nodes are kept in continuity to the
ovarian vessel system as shown on the right.
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with adherent right periaortic nodes (Figure 5).Step 5
Together with the left periaortic node dissection, the left
ovarian vein and artery are resected at their origin [12],
and mobilized laterally and dorsally to the left colon mes-
entery and the left ureter, identically to the right (Figure 6).
Along the vessels, a channel dorsally to the sigmoid mes-
entery is prepared to the left pelvis at the level of the left
common iliac artery. The infundibulopelvic ligament to-
gether with the adherent infrarenal periaortic nodes is
then transferred to the pelvis through this channel
(Figure 7).Figure 5 Dissection of the ovarian artery and ovarian vein, at
the aortic and cava level, respectively. The right periaortic nodes
are left attached and represent the first draining nodes (compare to
Figure 2b).Step 6
Completion of the pelvic rtLNE as previously described
for endometrial cancer [12].Step 7
Incision of the peritoneum covering the round liga-
ment, the ovarian vessels, the utero-ovarian junctions
and the vascular mesometrium is performed. This man-
euver assures complete resection of both regions to-
gether with the ovaries and the connecting structures
(Figures 8, 9, 10).Figure 7 Transferral of the left infundibulopelvic ligament.
Following complete mobilization, the left infundibulopelvic ligament
is pulled through the sigmoid ‘tunnel’ to the pelvis together with
the left infrarenal periaortic nodes, to guarantee complete resection
of the mesonephric ovarian drainage and avoiding division of
the ligament.
Figure 8 Preparation of vascular anastomoses of the uterine
and ovarian vessel system containing the accordant lymph
drainage. Lateral peritoneal incision with preparation of the lateral
aspect of the vascular mesometrium and division of the
round ligament.
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Radical hysterectomy with complete resection of the vas-
cular mesometrium is performed as described in detail for
rTMMR [13]. However, the separation from its conjunc-
tion with the adnexa and infundibulopelvic ligaments can
be omitted. In endometrial cancer without cervical infil-
tration, the resection of ligamentous mesometria can also
be omitted.
Step 9
The same procedure is undertaken on the left side. As in
endometrial cancer, the tumor primarily arises in the
Müllerian compartment and it has to be demonstrated
that the vaginal wall (belonging to the same ontogenetic
compartment) at the level of resection presents definiteFigure 9 Ventral incision line to preserve the peritoneal
covering the uterine and ovarian vessel system ensures
complete resection.clear margins. Closure of the vagina can be undertaken
by running suture.
A postoperative specimen following rPMMR and rtLNE
in high-risk stage I endometrial cancer is shown in
Figures 11 and 12. The complex of vascular mesometrium
connected to the mesonephric infundibulopelvic vessel
system, responsible for the different pelvic and periaortic
pathways to the primary lymph basins, can clearly be iden-
tified (Figure 11). En bloc resection with the overlaying
peritoneum facilitates the complete and intact removal of
these connections (Figures 11 and 12). Connections to the
pelvic and periaortic lymph basins can also be preserved
when intended.
Results
In total, 42 patients received robotically-assisted laparo-
scopic surgery. Thirty-nine patients received rPMMR
with bilateral salpingo-oophorectomy (n = 12), additional
pelvic tLNE (n = 8) or pelvic and periaortic LNE (n = 19).
Three patients underwent completion of surgery follow-
ing hysterectomy and diagnosis of endometrial cancer
including resection of mesometria. Infundibulopelvic lig-
aments and tLNE were categorized as rPMMR with
tLNE. Another two patients received immediate second-
ary robotic surgery for periaortic LNE in case of clinic-
ally inconspicuous but histologically verified positive
pelvic nodes, and were also categorized as rPMMR with
pelvic and periaortic tLNE. In six cases, resection of liga-
mentous mesometria was added due to suspicion of add-
itional cervical involvement. The remaining three
patients received robotic total laparoscopic hysterectomy
(rTLH) only for stage IA endometrial cancer.
All operations were completed endoscopically without
switching to open surgery. No intraoperative complica-
tions occurred. All tumors were histologically resected R0,
but one tumor was diagnosed Rx (pT3b, pN1 (24/46)).
Mean lymph node count was 33 (± 11) and 35 (± 10) for
pelvic and pelvic/periaortic LNE, respectively. Overall,
the mean decrease (± SD) of perioperative hemoglobin
concentration (on the first postoperative day) was 2.4 g/dL
(± 1.3 g/dL), with the lowest difference in rTLH (0.7 g/dL
(± 0.6 g/dL)). The decrease following rPMMR was 2.1
g/dL (± 1.0 g/dL), with pelvic tLNE 2.6 g/dL ± 1.1 g/dL;
essentially the same for pelvic and periaortic tLNE
accounting for 2.6 g/dL ± 1.5 g/dL. Only one patient
required transfusion following rPMMR and pelvic tLNE,
with a preoperative hemoglobin concentration of 9.0 g/dL
(2.4%).
Postoperative complications were relatively rare and
corresponded to a total complication rate of 12%. One
patient had superficial vein thrombosis, another patient
had deep vein thrombosis, one patient developed an
infected lymph cyst, another patient developed transient
postoperative aphasia (all following rPMMR with pelvic
Figure 10 Dorsal incision line caudally of the uterine vessels identified through the intact peritoneum.
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function of micturition following rPMMR only.
Endometrial cancer patients with stage III tumors, ser-
ous histology and/or positive lymph nodes were treated
with six cycles of adjuvant platinum-based chemother-
apy (n = 11). No patients received adjuvant external
beam radiotherapy.
Two patients with endometrial cancer developed re-
current disease. The first patient with endometrial
cancer recurrence was a 26-year-old woman withFigure 11 Specimen of the uterus (ventral aspect) following rPMMR a
vessel system, without separation of connecting vessels and surround
indicated by arrows. rPMMR, robotic peritoneal mesometrial resection; rtLNobesity (BMI 57 kg/m2). This was the only patient
who required transfusion, showing a preoperative
hemoglobin concentration of 9.0 g/dL. The initial
tumor stage was pT1a, N0 (0/29), G3 and the histo-
pathology revealed an endometrioid tumor type. The
patient did not receive adjuvant treatment. One year
after initial diagnosis, the patient presented with liver
metastases and there was no evidence of relapse in
the pelvis. The second patient with endometrial can-
cer recurrence initially had a tumor stage of pT3b,nd rtLNE, showing the completely resected uterine and ovarian
ing tissue. The uterine and ovarian pathways of lymph drainage are
E, therapeutic lymphadenectomy.
Figure 12 Same specimen of the uterus (dorsal aspect) together with the pelvic nodes, kept in continuity with the uterine
drainage system.
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tumor was completely resected macroscopically, but
was shown to be histologically Rx, indicating that the
tumor had already transgressed compartment borders.
This patient received adjuvant chemotherapy with
carboplatin (area under curve (AUC) 5) and paclitaxel
175 mg/m2 d1, q3w over six cycles. After 11 months,
the patient presented with local pelvic recurrence and
liver metastases, and was treated with palliative chemo-
therapy. Both patients died from metastatic disease during
the observation period. There was no further recurrence
or deaths during follow-up. At present, recurrence-free
survival is 95% (40 out of 42 patients).Discussion
Currently, there is ongoing international debate about
the extent of surgery, mode of access and correct
choice of adjuvant treatment for intermediate/high-risk
endometrial cancer [1-6]. Despite prospective data
showing no benefit of adjuvant irradiation therapy, with
regard to overall survival for patients with endometrial
cancer, no relevant change in clinical routine has been
observed, at least following the first publications of the
Gynecologic Oncology Group-Adjuvant Radiation for
Intermediate Risk Endometrial Cancers (GOG99) and
Post Operative Radiation Therapy in Endometrial Car-
cinoma (PPORTEC1) [16]. Thus, highly effective and
potentially curative radiotherapy will be wasted in the
adjuvant setting, and will not be available for treatment
in cases of recurrent disease.With regard to the recurrence pattern of endometrial
cancer, approximately 30 to 50% of patients experience
locoregional recurrence, while the remaining patients
present with distant or concomitant distant and lo-
coregional recurrence [17-19]. Locoregional recur-
rences usually arise in the vagina as central pelvic
recurrence in the Müllerian compartment or at the pel-
vic side wall, typically in pelvic lymph nodes. Prognosis
is usually poor except for the isolated vaginal recur-
rence [20]. There is some evidence that more radical
surgery may lower locoregional recurrence, not only in
the pelvis [17,21] but also with respect to periaortic
nodes [22,23]. However, it is difficult to compare re-
sults from clinical studies due to the large variety of
surgical strategies and quality.
Thus, a standardization and clear definition of surgi-
cal procedures is urgently required, since surgery is
without doubt the mainstay in the treatment of primary
endometrial cancer. Data regarding LNE vary grossly
between different studies. If pelvic and periaortic LNE
is performed to provide regional cure by itself, then it
should, at least intentionally, be complete. Additionally,
the compartments at risk of lymph basins to be re-
moved need to be exactly defined.
Regarding tLNE, we recently proposed a surgical strat-
egy demonstrated by minimally invasive, robotically-
assisted surgery [12]. On the basis of preclinical and
clinical findings of ontogenetically-defined boundary for-
mation and strict border control [10], and the clinical re-
search on ontogenetic compartments of cancer spread in
gynecological cancer [11], the local and regional
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fined as they have been for cervical cancer. As outlined
already, there is no need for resection of the lymphatic
drainage region of the lower cervical Müllerian compart-
ment in endometrial cancer if the tumor is confined to
the uterine corpus. Additionally, lymph drainage of the
uterine corpus follows the ovarian vessels of the meso-
nephric origin directly to the periaortic nodes. Conse-
quently, these compartments need to be cleared by tLNE
in endometrial cancer.
If M Höckel’s concept of locoregional control by
compartment-based surgery alone holds true for endo-
metrial cancer, then the implementation of ontogenetic
anatomy in surgical strategies is crucial to achieve best
results in terms of local and regional tumor control. Fol-
lowing translation to robotic surgery, we demonstrate in
a first feasibility analysis that this method may be
reproduced and safely performed with regard to peri-
operative morbidity, irrespective of additional morbidity
and BMI of patients. Interestingly, there was no remark-
able difference in blood loss between the different ap-
proaches of rPMMR with or without LNE. However,
postoperative complications were more frequent in the
group with periaortic tLNE, which not surprisingly indi-
cates that extension of surgery and operation time play a
role in postoperative morbidity. There was not a single
isolated locoregional recurrence despite omitting exter-
nal beam radiotherapy generally.
Since the follow-up time of the patients is limited, at
present we cannot conclude that PMMR and rtLNE
exert excellent locoregional control without additional
radiotherapy; however, up until now, the postoperative
course does not seem to disprove it. Furthermore,
rPMMR and rtLNE were accompanied by relatively low
morbidity, with regard to the patients’ preoperative con-
dition, BMI and surgical radicalness. Due to the excel-
lent three-dimensional high-definition (3DHD) vision,
and the high precision and control of movements, this
technique can be considered outstandingly suited for
complex surgery maintaining a minimally invasive ap-
proach. It is evident that at least equal radicalness may
be achieved compared to open surgery. The possibility
of video documentation may be beneficial concerning
scientific, educational and forensic aspects.
From our experience of this first series of rPMMR with
and without rtLNE in endometrial cancer, compartment-
based surgery appears in an oncological manner to exert
excellent locoregional control combined with a low com-
plication rate, especially with regard to preexistent mor-
bidity of patients.
Conclusions
In conclusion, we suggest that the minimally invasive
approach of compartment-based oncologic surgery forendometrial cancer by robotic assistance is feasible and
safe, with regard to perioperative morbidity for patients
with locally-confined endometrial cancer. Herewith, we
present a proposal for compartment-based, robotically-
assisted surgery for intermediate/high-risk endometrial
cancer with the intention of locoregional control by
surgery alone. The next step will be to evaluate whether
we can achieve comparable results in endometrial can-
cer patients to the excellent monocentric data of
M Höckel in cervical cancer patients [7-9]. Certainly,
a greater number of patients, a longer follow-up time
and a multicenter approach will be mandatory for suffi-
cient analysis. This standardized and reproducible
surgical protocol could be the basis for evaluation with
regard to locoregional control by surgery alone, without
additional radiotherapy. Reflecting that the majority
of patients who will die from endometrial cancer
are also diagnosed with lung and liver metastases [24],
this collective of comprehensively and reproducibly
staged patients may be appropriate for the most im-
portant further development of systemic treatment
for distant control not compromised by concomitant
radiotherapy [2]. Finally, other surgical gynecologic
oncologists may refer to this technique to standardize
and compare surgical results of compartment-related
surgery in the treatment of intermediate/high-risk
endometrial cancer.
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